Epigenetic control of FOXP3 expression: the key to a stable regulatory T-cell lineage?
- PMID: 19114986
- DOI: 10.1038/nri2474
Epigenetic control of FOXP3 expression: the key to a stable regulatory T-cell lineage?
Abstract
Regulatory T (T(Reg)) cells constitute a unique T-cell lineage that has a crucial role in immunological tolerance. Several years ago, forkhead box P3 (FOXP3) was identified as the transcription factor that was responsible for determining the development and function of these cells. However, the underlying mechanisms that are involved in the regulation of the FOXP3 gene remain unclear and therefore preclude accurate identification and manipulation of T(Reg) cells. In this Progress article, we summarize recent advances in understanding how FOXP3 expression is controlled and highlight evidence suggesting that epigenetic regulation of the FOXP3 locus contributes to its role as a lineage-specification factor.
Similar articles
-
To be or not to be a Treg cell: lineage decisions controlled by epigenetic mechanisms.Sci Signal. 2011 Feb 1;4(158):pe4. doi: 10.1126/scisignal.2001783. Sci Signal. 2011. PMID: 21285410
-
Role of conserved non-coding DNA elements in the Foxp3 gene in regulatory T-cell fate.Nature. 2010 Feb 11;463(7282):808-12. doi: 10.1038/nature08750. Epub 2010 Jan 13. Nature. 2010. PMID: 20072126 Free PMC article.
-
Epigenetic control of thymic Treg-cell development.Eur J Immunol. 2015 Jan;45(1):11-6. doi: 10.1002/eji.201444577. Epub 2014 Nov 20. Eur J Immunol. 2015. PMID: 25348287 Review.
-
Foxp3 enhancers synergize to maximize regulatory T cell suppressive capacity.J Exp Med. 2021 Aug 2;218(8):e20202415. doi: 10.1084/jem.20202415. Epub 2021 Jun 4. J Exp Med. 2021. PMID: 34086055 Free PMC article.
-
Lineage stability and phenotypic plasticity of Foxp3⁺ regulatory T cells.Immunol Rev. 2014 May;259(1):159-72. doi: 10.1111/imr.12175. Immunol Rev. 2014. PMID: 24712465 Review.
Cited by
-
Regulatory CAR-T cells in autoimmune diseases: Progress and current challenges.Front Immunol. 2022 Aug 10;13:934343. doi: 10.3389/fimmu.2022.934343. eCollection 2022. Front Immunol. 2022. PMID: 36032080 Free PMC article. Review.
-
Post-infusion CAR TReg cells identify patients resistant to CD19-CAR therapy.Nat Med. 2022 Sep;28(9):1860-1871. doi: 10.1038/s41591-022-01960-7. Epub 2022 Sep 12. Nat Med. 2022. PMID: 36097223 Free PMC article.
-
Rapamycin/IL-2 combination therapy in patients with type 1 diabetes augments Tregs yet transiently impairs β-cell function.Diabetes. 2012 Sep;61(9):2340-8. doi: 10.2337/db12-0049. Epub 2012 Jun 20. Diabetes. 2012. PMID: 22721971 Free PMC article. Clinical Trial.
-
Ssu72 is a T-cell receptor-responsive modifier that is indispensable for regulatory T cells.Cell Mol Immunol. 2021 Jun;18(6):1395-1411. doi: 10.1038/s41423-021-00671-2. Epub 2021 Apr 13. Cell Mol Immunol. 2021. PMID: 33850312 Free PMC article.
-
FOXP3, a novel glioblastoma oncosuppressor, affects proliferation and migration.Oncotarget. 2012 Sep 22;3(10):1146-57. doi: 10.18632/oncotarget.644. Print 2012 Oct. Oncotarget. 2012. PMID: 23888189 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources